Medable is a technology company founded in 2015 that provides a cloud-based platform for clinical trial development. Its core offering is an end-to-end system designed for pharmaceutical sponsors, contract research organizations (CROs), healthcare providers, and patients to collaborate within clinical studies. The platform integrates a suite of tools including electronic Clinical Outcome Assessment (eCOA), decentralized clinical trial solutions, and study management software.
A central feature of Medable's technology is its use of agentic AI to streamline clinical development. The company's Studio and AI technology enables sponsors to build studies up to 35 times faster. The company's stated vision includes ambitious timelines for clinical trials, targeting one-day study startup, one-day patient enrollment, and one-year study conduct timelines. The platform is designed for global use and maintains compliance certifications for HIPAA, GDPR, ISO, FDA 21 CFR Part 11, and ICH E6(R2) GCP standards.
The company operates within the pharmaceutical, biotech, and clinical research verticals. It was founded by a physician-scientist whose experience with patient access challenges in clinical research informed the company's mission to accelerate the delivery of therapies to patients.
